[1]许红玉,梅育嘉,罗杰峰.神经节苷脂联合复方左旋多巴治疗帕金森病的效果[J].医学信息,2021,34(03):160-161.[doi:10.3969/j.issn.1006-1959.2021.03.045]
 XU Hong-yu,MEI Yu-jia,LUO Jie-feng.The Effect of Ganglioside Combined with Benserazide in the Treatment of Parkinson’s Disease[J].Medical Information,2021,34(03):160-161.[doi:10.3969/j.issn.1006-1959.2021.03.045]
点击复制

神经节苷脂联合复方左旋多巴治疗帕金森病的效果()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年03期
页码:
160-161
栏目:
药物与临床
出版日期:
2021-02-01

文章信息/Info

Title:
The Effect of Ganglioside Combined with Benserazide in the Treatment of Parkinson’s Disease
文章编号:
1006-1959(2021)03-0160-02
作者:
许红玉梅育嘉罗杰峰
(1.广西民族医院神经内科,广西 南宁 530001; 2.广西医科大学第二附属医院神经内科,广西 南宁 530007)
Author(s):
XU Hong-yuMEI Yu-jiaLUO Jie-feng
(1.Department of Neurology,Minzu Hospital of Guangxi Zhuang Autonomous Region,Nanning 530001,Guangxi,China; 2. Department of Neurology,the Second Affiliated Hospital of Guangxi Medical University,Nanning 530007,Guangxi,China)
关键词:
帕金森病复方左旋多巴神经节苷脂认知功能氧化应激指标
Keywords:
Parkinson’s diseaseBenserazideGangliosideCognitive functionOxidative stress index
分类号:
R742.5
DOI:
10.3969/j.issn.1006-1959.2021.03.045
文献标志码:
A
摘要:
目的 探讨神经节苷脂联合复方左旋多巴治疗帕金森病的效果。方法 选择2017年1月~2019年12月我院接受治疗的262例帕金森病患者作为研究对象,按照随机数表法分为观察组与对照组,每组131例。对照组给予复方左旋多巴治疗,观察组在对照组基础上联合神经节苷脂治疗,比较两组治疗前后认知功能与氧化应激指标[丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH)]变化。结果 治疗4周后,观察组MoCA评分高于对照组[(88.36±3.69)分vs(75.68±2.21)分],差异有统计学意义(P<0.05);观察组MDA水平低于对照组,SOD、GSH水平高于对照组,差异有统计学意义(P<0.05)。结论 神经节苷脂联合复方左旋多巴治疗帕金森病患者,可有效改善患者认知功能,减轻氧化应激反应。
Abstract:
Objective To investigate the effect of ganglioside combined with Benserazide in the treatment of Parkinson’s disease.Methods A total of 262 Parkinson’s disease patients who were treated in our hospital from January 2017 to December 2019 were selected as the research objects. They were divided into observation group and control group according to the random number table method, with 131 cases in each group.The control group was given Benserazide treatment, and the observation group was combined with ganglioside treatment on the basis of the control group. The cognitive function and oxidative stress indexes [malondialdehyde (MDA), superoxide dismutase (SOD), glutathione (GSH)] changes.Results After 4 weeks of treatment, the MoCA score of the observation group was higher than that of the control group [(88.36±3.69) points vs (75.68±2.21) points], the difference was statistically significant (P<0.05);The MDA level of the observation group was lower than that of the control group, and the levels of SOD and GSH were higher than the control group, the difference was statistically significant (P<0.05).Conclusion Ganglioside combined with Benserazide in the treatment of patients with Parkinson’s disease can effectively improve patients’ cognitive function and reduce oxidative stress.

参考文献/References:

[1]王源江,赵振强,许叶,等.恩他卡朋片联合左旋多巴片对帕金森病患者的临床研究[J].中国临床药理学杂志,2019,35(2):112-114. [2]汤春琼.司来吉兰与左旋多巴联用治疗帕金森病运动障碍的临床效果探析[J].中国现代药物应用,2018,12(23):82-83. [3]中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍专业.中国帕金森病的诊断标准(2016版)[J].中华神经科杂志,2016,49(4):268-271. [4]康蓓,慕生枝,李妮妮,等.艾地苯醌联合多巴丝肼治疗帕金森病的疗效及对氧化应激因子的影响[J].山西医药杂志,2019,48(16):1958-1960. [5]刘亘梁,陈慧敏,张美美,等.左旋多巴剂量与帕金森病异动症风险的相关性分析[J].中华老年心脑血管病杂志,2019,21(2):121-124. [6]祝莹,康林,罗晓静.神经节苷脂钠联合盐酸多奈哌齐对老年帕金森病患者运动功能及认知功能的影响[J].医疗装备,2018,31(4):20-21.

相似文献/References:

[1]王姝,莫英绪,王大成.帕金森病发病因素的研究现状[J].医学信息,2018,31(01):46.[doi:10.3969/j.issn.1006-1959.2018.01.017]
 WANG Shu,MO Ying-xu,WANG Da-cheng.Research Status of the Factors of Parkinson's Disease[J].Medical Information,2018,31(03):46.[doi:10.3969/j.issn.1006-1959.2018.01.017]
[2]刘 阳,王惠凌,安 迪,等.进行性核上性麻痹1例报告[J].医学信息,2018,31(05):192.[doi:10.3969/j.issn.1006-1959.2018.05.073]
[3]樊 毅.帕金森病嗅觉改变的相关性研究[J].医学信息,2018,31(17):95.[doi:10.3969/j.issn.1006-1959.2018.17.029]
 FAN Yi.Correlation Study of Olfactory Changes in Parkinson's Disease[J].Medical Information,2018,31(03):95.[doi:10.3969/j.issn.1006-1959.2018.17.029]
[4]侯晓丽,张亚慧,唐迎乐.人参皂苷Rg3对帕金森病模型大鼠多巴胺能神经元氧化应激的抑制作用[J].医学信息,2023,36(19):88.[doi:10.3969/j.issn.1006-1959.2023.19.018]
 HOU Xiao-li,ZHANG Ya-hui,TANG Ying-le.Inhibitory Effect of Ginsenoside Rg3 on Oxidative Stress in Dopaminergic Neurons of Parkinson’s Disease Model Rats[J].Medical Information,2023,36(03):88.[doi:10.3969/j.issn.1006-1959.2023.19.018]
[5]陈凤全.帕金森病的诊治现状及进展[J].医学信息,2020,33(12):43.[doi:10.3969/j.issn.1006-1959.2020.12.014]
 CHEN Feng-quan.Status and Progress of Diagnosis and Treatment of Parkinson’s Disease[J].Medical Information,2020,33(03):43.[doi:10.3969/j.issn.1006-1959.2020.12.014]
[6]张 磊,张巧俊,惠艳娉.经颅直流电刺激调控帕金森病抑郁相关的脑环路及机制[J].医学信息,2022,35(21):159.[doi:10.3969/j.issn.1006-1959.2022.21.043]
 ZHANG Lei,ZHANG Qiao-jun,HUI Yan-ping.Transcranial Direct Current Stimulation Regulates Depression-related Brain Circuits and Mechanism in Parkinson’s Disease[J].Medical Information,2022,35(03):159.[doi:10.3969/j.issn.1006-1959.2022.21.043]
[7]邓伟胜,楼云龙,苏中振.正电子发射断层扫描PET/CT在帕金森病患者早期诊断中的应用[J].医学信息,2020,33(18):170.[doi:10.3969/j.issn.1006-1959.2020.18.057]
 DENG Wei-sheng,LOU Yun-long,SU Zhong-zhen.Application of Positron Emission Tomography PET/CT in Early Diagnosis of Parkinson’s Disease[J].Medical Information,2020,33(03):170.[doi:10.3969/j.issn.1006-1959.2020.18.057]
[8]贺诗佳,孙 玲,张树山.脑内肾素-血管紧张素系统在帕金森病发病机制中的作用研究[J].医学信息,2021,34(03):34.[doi:10.3969/j.issn.1006-1959.2021.03.011]
 HE Shi-jia,SUN Ling,ZHANG Shu-shan.Study on the Role of Renin-angiotensin System in the Pathogenesis of Parkinson’s Disease[J].Medical Information,2021,34(03):34.[doi:10.3969/j.issn.1006-1959.2021.03.011]
[9]胡方婷,薛冬辉.运动-心理-睡眠护理干预对帕金森病患者负性情绪的影响[J].医学信息,2021,34(05):181.[doi:10.3969/j.issn.1006-1959.2021.05.053]
 HU Fang-ting,XUE Dong-hui.Effects of Exercise-psychological-sleep Nursing Intervention on Negative Emotions in Patients with Parkinson’s Disease[J].Medical Information,2021,34(03):181.[doi:10.3969/j.issn.1006-1959.2021.05.053]
[10]张 欣,王 伟,司伟岳,等.1-甲基-4-苯基-1,2,3,6四氢吡啶诱导小鼠嗅觉障碍的实验研究[J].医学信息,2021,34(07):82.[doi:10.3969/j.issn.1006-1959.2021.07.022]
 ZHANG Xin,WANG Wei,SI Wei-yue,et al.Experimental study on 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine-induced olfactory dysfunction in mice[J].Medical Information,2021,34(03):82.[doi:10.3969/j.issn.1006-1959.2021.07.022]

更新日期/Last Update: 1900-01-01